The New Licensee and the Glaucoma Work-Up
Dr. Alvarez received her Idaho optometry license ten weeks ago after six years of practice in another state. She completed a 40-hour therapeutic pharmaceutical agent course and a national therapeutic examination during optometry school, but her Idaho application was for the basic license only, and she never applied for the therapeutic credential. On a busy Tuesday a 61-year-old established patient presents with intraocular pressures of 30 mmHg OD and 27 mmHg OS, a 0.8 cup-to-disc ratio OD with a documented retinal nerve fiber layer defect, and a family history of glaucoma. Dr. Alvarez diagnoses primary open-angle glaucoma, prescribes latanoprost nightly OU, adds timolol twice daily, orders a visual field, and bills the visit with a glaucoma diagnosis. Her chart note is clear and complete. The office manager says, "Your license covers everything - the therapeutic certificate is just a piece of paper on the wall." An investigator later reviews the chart after an unrelated complaint and asks Dr. Alvarez to justify the prescribing.
1. Is Dr. Alvarez authorized to initiate this therapy? Walk through how the Board would analyze the question.
Read the worked answer
The Board asks two separate questions and keeps them separate: does the person hold a license to practice optometry in Idaho, and does that license, as actually issued, authorize the specific act? Idaho conditions therapeutic prescribing on a credential obtained through additional training and a separate application; it is not conferred by the basic license and it is not conferred by having once passed a course. Dr. Alvarez's license is valid, so her examination, refraction, and spectacle or contact lens work are lawful. Starting drug therapy for glaucoma is not, unless her license carries that authority.
The analysis does not turn on competence. Finishing a 40-hour course and a national exam proves she could qualify - not that she has qualified. Nor does the office manager's assurance, or the fact that other clinics prescribe freely, create authority; administrative custom is not law and is no defense to a scope complaint. The recognized narrow exception is immediate action to prevent imminent harm pending transfer of care - acute angle closure, a chemical burn, a roaring infection - not the elective initiation of lifelong therapy in a stable, cooperative patient who could have been referred the same day.
On these facts the Board would likely find the prescribing outside the scope of the license as issued, which is a ground for discipline independent of whether the drug choice was correct. Confirm the current statute and IDAPA rule text before citing a section number.
2. Setting aside the Board, what does she owe this patient now, and how should she handle the investigation?
Read the worked answer
The patient's interests come first. Abruptly stopping both drugs and sending him away would be abandonment and could cost him vision. She should arrange, the same day, for an optometrist who holds therapeutic authority or an ophthalmologist to assume the prescribing; transmit the record with the pressures, disc findings, visual field order, and the start date of each medication; and document the handoff and the conversation, including what she told the patient. She should be straightforward with him that another clinician will manage the drops, without blaming staff.
Then: apply for the therapeutic credential and do not prescribe again until it issues. As to the investigation, respond truthfully and completely in writing, produce the chart unaltered, and avoid the two classic aggravators - editing or backdating the note, and later recasting the visit as a "referral" it never was. The record she wrote is actually her best evidence: it shows a defensible work-up and shows exactly what she did. Most boards treat prompt self-correction, no patient harm, and full cooperation as mitigating; continued prescribing after notice, incomplete disclosure, and delay are aggravating. Retaining counsel before an interview is appropriate and is not obstruction.